A systematic review and meta-analysis of thermal coagulation compared with cryotherapy to treat precancerous cervical lesions in low- and middle-income countries

Review (2019)
Author(s)

Marlieke de Fouw (Leiden University Medical Center)

Roos M. Oosting (TU Delft - Medical Instruments & Bio-Inspired Technology)

Amy Rutgrink (Leiden University Medical Center)

O. M. Dekkers (Leiden University Medical Center)

Alexander Arnold Willem Peters (Leiden University Medical Center)

Jogchum Jan Beltman (Leiden University Medical Center)

Research Group
Medical Instruments & Bio-Inspired Technology
Copyright
© 2019 Marlieke de Fouw, R.M. Oosting, Amy Rutgrink, Olaf Matthijs Dekkers, Alexander Arnold Willem Peters, Jogchum Jan Beltman
DOI related publication
https://doi.org/10.1002/ijgo.12904
More Info
expand_more
Publication Year
2019
Language
English
Copyright
© 2019 Marlieke de Fouw, R.M. Oosting, Amy Rutgrink, Olaf Matthijs Dekkers, Alexander Arnold Willem Peters, Jogchum Jan Beltman
Research Group
Medical Instruments & Bio-Inspired Technology
Issue number
1
Volume number
147
Pages (from-to)
4-18
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Background: Thermal coagulation is gaining popularity for treating cervical intraepithelial neoplasia (CIN) in screening programs in low- and middle-income countries (LMICs) due to unavailability of cryotherapy. Objectives: Assess the effectiveness of thermal coagulation for treatment of CIN lesions compared with cryotherapy, with a focus on LMICs. Search strategy: Papers were identified from previous reviews and electronic literature search in February 2018 with publication date after 2010. Selection criteria: Publications with original data evaluating cryotherapy or thermal coagulation with proportion of cure as outcome, assessed by colposcopy, biopsy, cytology, and/or visual inspection with acetic acid (VIA), and minimum 6 months follow-up. Data collection and analysis: Pooled proportions of cure are presented stratified per treatment modality, type of lesion, and region. Main results: Pooled cure proportions for cryotherapy and thermal coagulation, respectively, were 93.8% (95% CI, 88.5–97.7) and 91.4% (95% CI, 84.9–96.4) for CIN 1; 82.6% (95% CI, 77.4–87.3) and 91.6% (95% CI, 88.2–94.5) for CIN 2–3; and 92.8% (95% CI, 85.6–97.7) and 90.1% (95% CI, 87.0–92.8) for VIA-positive lesions. For thermal coagulation of CIN 2–3 lesions in LMICs 82.4% (95% CI, 75.4–88.6). Conclusions: Both cryotherapy and thermal coagulation are effective treatment modalities for CIN lesions in LMICs.